X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4623) 4623
Publication (274) 274
Book Review (46) 46
Book Chapter (16) 16
Book / eBook (5) 5
Conference Proceeding (5) 5
Magazine Article (5) 5
Newsletter (4) 4
Newspaper Article (4) 4
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2665) 2665
male (1734) 1734
humans (1579) 1579
tryptamines - pharmacology (1544) 1544
rats (1415) 1415
pharmacology & pharmacy (1035) 1035
index medicus (840) 840
tryptamines (815) 815
female (791) 791
mice (580) 580
neurosciences (520) 520
serotonin (491) 491
migraine (483) 483
migraine disorders - drug therapy (472) 472
in vitro techniques (461) 461
dose-response relationship, drug (450) 450
tryptamines - metabolism (437) 437
serotonin - metabolism (419) 419
adult (400) 400
serotonin - pharmacology (389) 389
secologanin tryptamine alkaloids - pharmacology (341) 341
tryptamine (327) 327
time factors (321) 321
brain - metabolism (303) 303
clinical neurology (296) 296
rats, inbred strains (295) 295
pharmacology (284) 284
serotonin receptor agonists - pharmacology (282) 282
kinetics (275) 275
middle aged (274) 274
tryptamines - therapeutic use (267) 267
sumatriptan (264) 264
chemistry, medicinal (262) 262
receptors, serotonin - drug effects (260) 260
serotonin receptor agonists - therapeutic use (258) 258
biochemistry & molecular biology (245) 245
structure-activity relationship (240) 240
melatonin - pharmacology (235) 235
indoles - pharmacology (230) 230
indoles (229) 229
antihypertensive agents (226) 226
melatonin (225) 225
alkaloids (223) 223
behavior, animal - drug effects (212) 212
brain (211) 211
rabbits (209) 209
brain - drug effects (206) 206
receptors (205) 205
drugs (204) 204
tryptamines - chemistry (204) 204
tryptamines - administration & dosage (188) 188
monoamine oxidase inhibitors - pharmacology (184) 184
research (179) 179
amines (178) 178
psychiatry (175) 175
rats, sprague-dawley (175) 175
headache (171) 171
receptors, serotonin - metabolism (171) 171
serotonin antagonists - pharmacology (171) 171
n,n-dimethyltryptamine - pharmacology (170) 170
triptans (165) 165
hallucinogens - pharmacology (157) 157
molecular structure (152) 152
5-hydroxytryptamine (151) 151
blood pressure - drug effects (151) 151
double-blind method (146) 146
treatment outcome (146) 146
reserpine (144) 144
double-blind (143) 143
analysis (139) 139
lysergic acid diethylamide - pharmacology (139) 139
pharmacokinetics (139) 139
zolmitriptan (138) 138
serotonin receptor agonists - adverse effects (136) 136
guinea pigs (135) 135
reserpine - pharmacology (134) 134
adolescent (133) 133
cats (133) 133
dogs (133) 133
dopamine - metabolism (129) 129
drug interactions (129) 129
n,n-dimethyltryptamine (129) 129
norepinephrine - metabolism (129) 129
monoamine oxidase - metabolism (128) 128
motor activity - drug effects (128) 128
metabolism (127) 127
rats, wistar (127) 127
administration, oral (126) 126
tryptamines - adverse effects (126) 126
heterocyclic compounds (125) 125
hallucinogens (124) 124
drug therapy (123) 123
organic nitrogen compounds (123) 123
secologanin tryptamine alkaloids (123) 123
5-ht (121) 121
organic compounds (121) 121
pyrroles (119) 119
azoles (118) 118
chemistry (118) 118
dopamine (118) 118
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4212) 4212
Russian (140) 140
French (109) 109
German (109) 109
Japanese (51) 51
Italian (24) 24
Chinese (14) 14
Spanish (11) 11
Polish (9) 9
Czech (4) 4
Danish (4) 4
Hungarian (3) 3
Portuguese (3) 3
Dutch (2) 2
Swedish (2) 2
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Handbook of clinical neurology, ISSN 0072-9752, 2010, Volume 97, p. 47
Headache treatment has been based primarily on experiences with non-specific drugs such as analgesics, non-steroidal anti-inflammatory drugs, or drugs that... 
Anti-Inflammatory Agents, Non-Steroidal | Analgesics - therapeutic use | Serotonin | Migraine Disorders | Humans | Serotonin Receptor Agonists | Tryptamines
Journal Article
Journal Article
Journal Article
Phytochemistry, ISSN 0031-9422, 09/2015, Volume 117, pp. 317 - 324
Four alkaloids comprising two vallesamine, one strychnan, and pyranopyridine alkaloid were isolated from two Malayan species, and . Several of the isolated... 
Apocynaceae | NMR | Cytotoxicity | Alstonia rostrata | Vasorelaxation | Indole alkaloids | Alstonia pneumatophora | MACROPHYLLA | BIOCHEMISTRY & MOLECULAR BIOLOGY | BISINDOLE ALKALOIDS | MACROLINE-MACROLINE | PLANT SCIENCES | ANGUSTIFOLIA | A-D | SARPAGINE | ALSMAPHORAZINES | DERIVATIVES | Carbazoles - chemistry | Pyridines - chemistry | Humans | Crystallography, X-Ray | Cell Line, Tumor - drug effects | Alstonia - chemistry | Heterocyclic Compounds, 4 or More Rings - pharmacology | Phenylephrine - pharmacology | Pyrans - chemistry | Aldehydes - pharmacology | Lactams - pharmacology | Molecular Structure | Indole Alkaloids - chemistry | Pyrans - pharmacology | Drug Evaluation, Preclinical - methods | Alkaloids - pharmacology | Secologanin Tryptamine Alkaloids - chemistry | Secologanin Tryptamine Alkaloids - pharmacology | Vasodilator Agents - pharmacology | Aorta - drug effects | Heterocyclic Compounds, 4 or More Rings - chemistry | Rats | Antineoplastic Agents, Phytogenic - chemistry | Animals | Indolizines - chemistry | Indole Alkaloids - pharmacology | Vasodilator Agents - chemistry | Pyridines - pharmacology | Antineoplastic Agents, Phytogenic - pharmacology | Carbazoles - pharmacology | Alkaloids - chemistry | Indolizines - pharmacology | Aldehydes - chemistry | Lactams - chemistry | Alkaloids | Analysis | Nuclear nonproliferation
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 10/2010, Volume 32, Issue 5, pp. 544 - 549
In recent years, besides the classic designer drugs of the amphetamine type, a series of new drug classes appeared on the illicit drugs market. The chemistry,... 
drugs of abuse | herbal drugs | metabolism | designer drugs | pharmacology | HEPATIC CYTOCHROME-P450 ISOZYMES | MAIN METABOLITES | ISOLATED RAT HEPATOCYTES | CHROMATOGRAPHY-MASS-SPECTROMETRY | DESIGNER DRUG | MITRAGYNA-SPECIOSA | TOXICOLOGICAL DETECTION | HALLUCINOGENIC MESCALINE ANALOGS | QUANTITATIVE STRUCTURE-ACTIVITY | PHARMACOLOGY & PHARMACY | TOXICOLOGY | MEDICAL LABORATORY TECHNOLOGY | 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE 2C-B | Substance Abuse Detection - methods | Phencyclidine - pharmacology | Phencyclidine - chemistry | Designer Drugs - metabolism | Amphetamines - pharmacology | Humans | Drugs, Chinese Herbal - pharmacology | Street Drugs - metabolism | Piperazines - metabolism | Piperazines - chemistry | Drugs, Chinese Herbal - metabolism | Forensic Toxicology - methods | Cannabinoids - metabolism | Mitragyna | Amphetamines - chemistry | Designer Drugs - pharmacology | Substance-Related Disorders - metabolism | Phenethylamines - pharmacology | Secologanin Tryptamine Alkaloids - chemistry | Secologanin Tryptamine Alkaloids - pharmacology | Cannabinoids - chemistry | Phenethylamines - chemistry | Phenethylamines - metabolism | Secologanin Tryptamine Alkaloids - metabolism | Piperazines - pharmacology | Cannabinoids - pharmacology | Designer Drugs - chemistry | Animals | Amphetamines - metabolism | Drugs, Chinese Herbal - chemistry | Phencyclidine - metabolism | Street Drugs - pharmacology | Street Drugs - chemistry | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 10/2014, Volume 231, Issue 20, pp. 3973 - 3985
Journal Article
Psychopharmacology, ISSN 0033-3158, 2/2012, Volume 219, Issue 4, pp. 1039 - 1053
Ayahuasca is an Amazonian tea containing the natural psychedelic 5-HT2A/2C/1A agonist N,N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its... 
Neurosciences | Biomedicine | Ayahuasca | Tolerance | Psychedelics | Repeated dose administration | Pharmacology/Toxicology | Psychiatry | PSYCHOACTIVE BEVERAGE AYAHUASCA | N,N-DIMETHYLTRYPTAMINE | PSYCHIATRY | 5-HT2A RECEPTOR | DOWN-REGULATION | HUMANS | NEUROSCIENCES | LYSERGIC-ACID DIETHYLAMIDE | RESPONSES | PHARMACOLOGY & PHARMACY | HEALTHY-VOLUNTEERS | RATING-SCALE | Hallucinogens - administration & dosage | Hallucinogens - pharmacology | Double-Blind Method | Drug Administration Schedule | Plant Extracts - pharmacology | Humans | Drug Tolerance | N,N-Dimethyltryptamine - pharmacology | N,N-Dimethyltryptamine - administration & dosage | Male | Banisteriopsis - chemistry | Cross-Over Studies | Plant Extracts - administration & dosage | Young Adult | Heart Rate - drug effects | N,N-Dimethyltryptamine - isolation & purification | Time Factors | Adult | Blood Pressure - drug effects | Growth Hormone - secretion | Hallucinogens - isolation & purification | Tea - chemistry | Cytokinins | Somatotropin | Lactose | Corticosteroids | Physiological aspects | Hallucinogenic drugs | Pharmacology | Clinical trials | Cardiovascular disease | Drug therapy | Placebo effect | Drug abuse | Serotonin S2 receptors | Hydrocortisone | Immunity | Immunological tolerance | Heart rate | Tea | Autonomic nervous system | Prolactin | Blood pressure | Growth hormone
Journal Article
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 11/2007, Volume 34, Issue 11, pp. 1199 - 1206
SUMMARY • In the present study, we investigated how alloxan-induced diabetes affects the ability of 5-hydroxytryptamine (5-HT) to modulate bradycardia induced... 
5-HT1 receptors | 5-hydroxytryptamine | alloxan-induced diabetes | vagally induced bradycardia | 5‐HT1 receptors | 5‐hydroxytryptamine | alloxan‐induced diabetes | Vagally induced bradycardia | receptors | 5-HT | Alloxan-induced diabetes | PHYSIOLOGY | 5-HT7 RECEPTORS | URINARY-BLADDER | PHARMACOLOGICAL CHARACTERIZATION | ACETYLCHOLINE-RELEASE | M-2 MUSCARINIC RECEPTORS | AUTONOMIC NEUROPATHY | ANESTHETIZED RABBITS | PARASYMPATHETIC INNERVATION | PHARMACOLOGY & PHARMACY | SYMPATHETIC-STIMULATION | 5-HT1-LIKE RECEPTORS | Serotonin - administration & dosage | Electric Stimulation | Injections, Intravenous | Methiothepin - pharmacology | Rats, Wistar | Cholinergic Agents - pharmacology | Male | Serotonin - pharmacology | Receptors, Serotonin, 5-HT1 - metabolism | Serotonin Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Heart Rate - drug effects | Bradycardia - metabolism | Biphenyl Compounds - pharmacology | Tryptamines - pharmacology | Oxadiazoles - pharmacology | Diabetes Mellitus, Experimental - metabolism | Diabetes Mellitus, Experimental - physiopathology | Heart - innervation | Acetylcholine - pharmacology | Bradycardia - physiopathology | Rats | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Serotonin Antagonists - pharmacology | Piperazines - pharmacology | Vagus Nerve - physiopathology | Animals | Serotonin - metabolism | Heart - drug effects | Serotonin - analogs & derivatives | Pyridines - pharmacology | Receptors, Serotonin, 5-HT1 - drug effects | Blood Glucose - metabolism | Ergolines - pharmacology | Ergolines, pharmacology | Serotonin, pharmacology | Receptors, Serotonin, 5-HT1, metabolism | Bradycardia, metabolism | 8-Hydroxy-2-(di-n-propylamino)tetralin, pharmacology | Serotonin, metabolism | Bradycardia, physiopathology | Piperazines, pharmacology | Vagus Nerve, physiopathology | Serotonin, administration and dosage | Biphenyl Compounds, pharmacology | Pyridines, pharmacology | Tryptamines, pharmacology | Serotonin, analogs and derivatives | Serotonin Antagonists, pharmacology | Serotonin Agonists, pharmacology | Heart Rate | Receptors, Serotonin, 5-HT1, drug effects | Diabetes Mellitus, Experimental, physiopathology | Acetylcholine, pharmacology | Heart Rate, drug effects | Diabetes Mellitus, Experimental, metabolism | Methiothepin, pharmacology | Oxadiazoles, pharmacology | Blood Glucose, metabolism | Heart, innervation | Cholinergic Agents, pharmacology | Heart, drug effects | Diabetes
Journal Article